Literature DB >> 8581511

Antiangiogenesis as a novel therapeutic concept in pediatric oncology.

L Schweigerer1.   

Abstract

Mesh:

Year:  1995        PMID: 8581511     DOI: 10.1007/bf00198901

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  134 in total

Review 1.  Angiogenesis in the female reproductive system.

Authors:  L P Reynolds; S D Killilea; D A Redmer
Journal:  FASEB J       Date:  1992-02-01       Impact factor: 5.191

2.  Preclinical wound-healing studies with recombinant human basic fibroblast growth factor.

Authors:  J C Fiddes; P A Hebda; P Hayward; M C Robson; J A Abraham; C K Klingbeil
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

Review 3.  Treatment of hemangiomatosis with recombinant interferon alfa.

Authors:  C W White
Journal:  Semin Hematol       Date:  1990-07       Impact factor: 3.851

Review 4.  Endothelial injury caused by antineoplastic agents.

Authors:  J S Lazo
Journal:  Biochem Pharmacol       Date:  1986-06-15       Impact factor: 5.858

5.  Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells.

Authors:  Y Sato; M Abe; R Takaki
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

6.  Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.

Authors:  S Kondo; M Asano; H Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1993-08-16       Impact factor: 3.575

7.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  Basic fibroblast growth factor is present in cultured human retinoblastoma cells.

Authors:  L Schweigerer; G Neufeld; D Gospodarowicz
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-11       Impact factor: 4.799

9.  The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution. Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine.

Authors:  P Sharon; E A Drab; J S Linder; S W Weidman; S M Sabesin; D B Rubin
Journal:  J Lab Clin Med       Date:  1992-01

10.  Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours.

Authors:  V W Li; R D Folkerth; H Watanabe; C Yu; M Rupnick; P Barnes; R M Scott; P M Black; S E Sallan; J Folkman
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

View more
  8 in total

Review 1.  Therapeutic inhibition of angiogenesis.

Authors:  Hua-Tang Zhang; Roy Bicknell
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

2.  Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.

Authors:  Yolanda Piña; Samuel K Houston; Timothy G Murray; Hinda Boutrid; Magda Celdran; William Feuer; Wei Shi; Eleut Hernandez; Theodore J Lampidis
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-11       Impact factor: 4.799

3.  Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.

Authors:  Pina Fortunato; Serena Pillozzi; Angela Tamburini; Liliana Pollazzi; Alessandro Franchi; Agostino La Torre; Annarosa Arcangeli
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

4.  Higher vessel densities in retinoblastoma with local invasive growth and metastasis.

Authors:  Jochen Rössler; Torsten Dietrich; Helena Pavlakovic; Lothar Schweigerer; Werner Havers; Andreas Schüler; Norbert Bornfeld; Harald Schilling
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

5.  Acacetin inhibits in vitro and in vivo angiogenesis and downregulates Stat signaling and VEGF expression.

Authors:  Tariq A Bhat; Dhanya Nambiar; Dhanir Tailor; Arttatrana Pal; Rajesh Agarwal; Rana P Singh
Journal:  Cancer Prev Res (Phila)       Date:  2013-08-13

6.  Analysis of aqueous humor concentrations of cytokines in retinoblastoma.

Authors:  Yong Cheng; Shufeng Zheng; Chung-Ting Pan; Mengke Yuan; Libin Chang; Yuou Yao; Mingwei Zhao; Jianhong Liang
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

7.  Lack of effect of SU1498, an inhibitor of vascular endothelial growth factor receptor-2, in a transgenic murine model of retinoblastoma.

Authors:  C M Cebulla; M E Jockovich; H Boutrid; Y Piña; M Ruggeri; S Jiao; S K Bhattacharya; W J Feuer; T G Murray
Journal:  Open Ophthalmol J       Date:  2008-04-02

8.  Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice.

Authors:  Y Hamma-Kourbali; A Starzec; R Vassy; A Martin; M Kraemer; G Perret; M Crépin
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.